GlassScriptPhysician profile
Aysha Syed
NPI 1790021392
$611.55
in general payments reported to CMS, 2019-2025
21 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $53.29 · 2021: $18.78 · 2022: $78.71 · 2023: $110 · 2024: $56.53 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $96.33 | 2019-2025 | |
| Neos Therapeutics, LP | $73.31 | 2019 | |
| Lilly USA, LLC | $49.69 | 2023-2025 | Jardiance, Emgality |
| Ironshore Pharmaceuticals INC. | $42.95 | 2019 | |
| Mylan Specialty L.P. | $36.03 | 2023-2024 | Yupelri |
| Novo Nordisk INC | $34.12 | 2022-2024 | Rybelsus, Ozempic |
| Genentech USA, INC. | $33.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.25 | 2019-2020 | |
| Lundbeck LLC | $26.71 | 2023 | Rexulti |
| Eisai INC. | $22.07 | 2023 | |
| Supernus Pharmaceuticals, INC. | $18.78 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.78 | 2022 | |
| Nevro Corp. | $16.83 | 2022 | |
| Amgen INC. | $16.80 | 2023 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $15.82 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.25 | 2022 | |
| Merck Sharp & Dohme LLC | $14.08 | 2025 | Vaxneuvance, Capvaxive, Vaxelis |
| Kaleo, INC. | $12.99 | 2020 | |
| Exact Sciences Corporation | $12.94 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $11.90 | 2022 | |
| Glaxosmithkline, LLC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aysha Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.